Hanan Bouchaab

University of Lausanne

Papers

1

Total Citations

32

H-Index

1

About

Dr. Hanan Bouchaab is a leading surgical oncologist whose research centers on optimizing treatment de-escalation strategies for oropharyngeal cancer (OPC), particularly through transoral robotic surgery (TORS). Her most impactful work, a prospective observational cohort study (32 citations), demonstrated that by combining rigorous surgical margin revision with the exclusion of radiographic extracapsular extension (ECS), it is possible to safely minimize adjuvant therapy after TORS. This contribution directly challenges traditional paradigms of aggressive post-surgical treatment, offering patients a pathway to reduced toxicity without compromising oncologic outcomes. By prospectively validating a selection protocol that spares many patients from unnecessary radiotherapy or chemotherapy, Dr. Bouchaab has provided a critical evidence base for personalized, function-preserving head and neck cancer care. Her work is widely cited by surgeons and radiation oncologists seeking to refine de-escalation protocols, marking her as a key voice in the movement toward less morbid, yet equally effective, multidisciplinary management of OPC.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study
32 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Lausanne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago